Gilead Sciences Inc. (NASDAQ:GILD) agreed to make its hepatitis C medicines the exclusive treatments for CVS Health Corp. (CVS) customers, intensifying a drug-industry rivalry to win patients for the $1,000-a-day medicines. Gilead Sciences Inc. (NASDAQ:GILD) in last trading activity moved up 1.98% to close at $96.79. Company weekly performance is 3.19% while its quarterly performance stands at -9.14%. Gilead Sciences Inc. (NASDAQ:GILD) is -17.16% away from its 52 week high.
ArcelorMittal SA (NYSE:MT) has received a consensus recommendation of “Hold” from the eighteen ratings firms that are presently covering the company, Analyst Ratings.Net reports. Four research analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $16.67. On last trading day ArcelorMittal SA (ADR) (NYSE:MT) moved down -4.61% to close at $10.34. Its volatility for the week is 1.74% while volatility for the month is 2.37%. MT’s sales growth for past 5 years was -7.40% and its EPS growth for past 5 years was -17.30%. ArcelorMittal SA (ADR) (NYSE:MT) monthly performance is -15.59%.
BBVA Banco Frances SA (NYSE:BFR) institutional ownership stands at 4.50%. In last trading activity company’s stock closed at $13.08.
IGI Laboratories Inc. (NYSEMKT:IG) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 3,886,110 shares, an increase of 81.8% from the November 28th total of 2,137,204 shares, AnalystRatingsNetwork reports. On Monday shares of IGI, Laboratories, Inc. (NYSEMKT:IG) closed at $9.02. Company’s sales growth for last 5 years was 34.70% and EPS growth for next 5 years is recorded as 15.00%.
CVD Equipment Corporation (NASDAQ:CVV) CEO Leonard A. Rosenbaum sold 7,670 shares of the stock on the open market in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $15.02, for a total transaction of $115,203.40. Following the sale, the chief executive officer now directly owns 847,761 shares in the company, valued at approximately $12,733,370. On last trading day CVD Equipment Corporation (NASDAQ:CVV) moved up 1.30% to close at $14.75. Its volatility for the week is 4.12% while volatility for the month is 3.62%. CVV’s sales growth for past 5 years was -0.20% and its EPS growth for past 5 years was -21.90%. CVD Equipment Corporation (NASDAQ:CVV) monthly performance is 0.07%.